Announced Mon, 23 Mar · 18:55 IST
The company has successfully completed capacity expansion at Dehradun plant. Please refer the attached documents.
Capex & Operations View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-5.8%1-day move
₹404.70
prior close
₹409.70
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.7+0.8+0.8+1.8-5.8-9.2-8.3-5.4-2.4-2.4+1.6+5.5+22.6+59.1
Up moveDown movePending
AI summary
Coral Laboratories has completed the capacity expansion of its General Pharmaceuticals Formulation (Ointment) unit at the Dehradun plant, raising capacity to 360,000 kgs. The company has commenced commercial operations at the expanded facility. This follows the company's earlier intimation dated October 13, 2025. No financial details of the capex were disclosed in the filing.
Likely market impact
The expanded capacity should support higher production volumes and potentially better revenue going forward, but the absence of capex details means investors cannot fully assess the return profile or impact on margins.